Linghan Jia is a member of the Endocrine Hypertension Research group in the Centre for Endocrinology and Metabolism.
Areas of interest
Linghan Jia manages the CONSEP (CONn Syndrome Evaluation in Primary Care) trial which aims to test whether intervention can increase primary aldosteronism (PA) screening among patients living with hypertension. This pragmatic cluster randomised controlled trial will generate scalable strategies to increase the identification of PA in hypertensive patients and lead to improved outcomes for patients living with PA. Using principles of implementation science and health economics, CONSEP is being implemented in general practices in Victoria, Tasmania and South Australia.
Read more Endocrine hypertension